Lack of data mires Aranesp in controversy.
Wadman
Meredith
M
D000068256:Darbepoetin alfa; D004345:Drug Industry / Q000191:economics*; D000068817:Epoetin Alfa; D004921:Erythropoietin / Q000031:analogs & derivatives* / Q000191:economics / Q000627:therapeutic use; D006397:Hematinics / Q000191:economics* / Q000627:therapeutic use; D006801:Humans; D011994:Recombinant Proteins; D012107:Research Design
D006397:Hematinics; D011994:Recombinant Proteins; D004921:Erythropoietin; D000068256:Darbepoetin alfa; D000068817:Epoetin Alfa